Abstract:The infrared system IRATHERM-2000, with water-filtered infrared A wavelength underwent 20 treatments of whole body hyperthermia in conjunction with chemotherapy. In all the sessions, the aimed systemic temperature (41.8 degrees C, maximum 42.0 degrees C) could be achieved and maintained for 60 min. Due to increasing clinical experience, the unnegligible local toxicity, exhibited as heat-induced superficial lesions, and neurotoxicity, could be reduced during the course of the study. Data from three other series accomplished at the von Ardenne Clinic, totalling 120 heat sessions, were available and included for a comparative analysis. Analysis of the toxicity shows that a correlation exists between thermal side-effects and heat-up periods (until steady-state), maximum temperatures, and superficial thermal doses. The time needed to reach the plateau seems to correlate with fluid loss, which, thus, indirectly influences toxicity, and most importantly the initial power level. The typical heat-up time in such a standard set-up amounts to 100-150 min, for a temperature rise from 37.5 to 42.0 degrees C. Evaluation of the energy balance reveals a highly patient-specific range for the reactive evaporation in the IRATHERM system, resulting in a power (heat) loss of up to 1400 W via sweat production of approximately 2 l/h. In order to counterbalance this effect, an accordingly high infrared power, ranging from 1200-1500 W, needs to be delivered, resulting in a significant thermal skin exposition. Concepts used to reduce the heat loss by reactive evaporation include prevention of convection by appropriate sealing of the heating chamber and increasing the humidity by a nebulizer. For the more trained user, the heat-up time can be considerably shortened, particularly, in the introductory phase of the heating process, by employing higher, but still tolerable, patient-specific power levels. However, such a strategy requires, due to higher risks, close monitoring of skin temperatures together with a considerable amount of clinical experience. The results of the IRATHERM pilot study were compared, not only with previous groups where the IRATHERM was applied, but also with results of various other investigators where the Enthermics Radiant Heat Device was employed. In the authors' opinion, improved understanding of the mechanisms and crucial parameters underlying whole body hyperthermia, will enable a controllable and tolerable therapy through proficient contribution to equipment and methods.

In-vitro hyperthermia studied by cellular impedance sensors

In vitro hyperthermia studied in a continuous manner using electric impedance sensing

In Vitro Hyperthermia Based on a Multi-Mode Detection Chip with Impedance Sensing

Enhanced Damage Effects Induced by Cell-Level Hyperthermia with Higher Heating Rate or Allied Cooling Procedure

Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy

Susceptibility of epithelial tumour cell lines to hyperthermia

Temperature Tolerance Electric Cell-Substrate Impedance Sensing for Joint Assessment of Cell Viability and Vitality

Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cells

A dynamic study of the cytotoxic effects of hyperthermia combined with cis-diamine dichlorolplatinum (DDP) on human gastric cancer cell lines MKN28 and MKN45 in vitro

THEORETICAL EVALUATION ON THE THERMAL EFFECTS OF EXTRACELLULAR HYPERTHERMIA AND INTRACELLULAR HYPERTHERMIA

Using electrical impedance detection to evaluate the viability of biomaterials subject to freezing or thermal injury

Feasibility and analysis of thermal parameters for the whole-bodyhyperthermia system IRATHERM-2000

Hyperthermia enhances the efficacy of chemotherapeutic drugs in heat-sensitive cells through interfering with DNA damage repair

In vivo hyperthermia effect induced by high-intensity pulsed ultrasound

Mapping Of Hyperthermic Tumor Cell Death In A Microchannel Under Unidirectional Heating

Contribution of A 300 Khz Alternating Magnetic Field on Magnetic Hyperthermia Treatment of Hepg2 Cells

In vivo electrical properties of the healthy liver and the hepatic tumor in a mouse model between 1 Hz and 1 MHz during a thermal treatment

Hyperthermia treatment of dose-response relationship study in human cervical carcinoma Hela cells

Multiscale Effect of Localized Heating on the Global Temperature Response of a Human Body During Whole-Body Hyperthermia

Effect of Hyperthermia on Invasion Ability and TGF-β1 Expression of Breast Carcinoma MCF-7 Cells.

Feasibility Study of High-Temperature Thermoseed Inductive Hyperthermia in Melanoma Treatment